Trials

ClotChip® received FDA breakthrough device designation in March 2020, and is currently in clinical trials. A list of feasibility studies on the ClotChip® sensor include the following:

Pilot Studies

XaTek ClotChip System – Blood Sample Collection Protocol CP-002

XaTek Inc.
Status: enrollment open
Sponsor: XaTek Inc.

XaTek ClotChip System – Blood Sample Collection

XaTek Inc.
Status: enrollment closed
Sponsor: XaTek Inc.

Hypercoagulability in COVID-19 infections – Developing biomarkers of prognosis

University Hospitals of Cleveland
Status: enrollment closed
Sponsor: XaTek Inc.

ClotChip® as a pre-surgical screening tool

University Hospitals of Cleveland
Status: enrollment closed; N=100

1 2

Questions?